SEI Medical PCL Statistics
Total Valuation
SEI Medical PCL has a market cap or net worth of THB 387.60 million. The enterprise value is 311.77 million.
| Market Cap | 387.60M |
| Enterprise Value | 311.77M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | Mar 12, 2026 |
Share Statistics
SEI Medical PCL has 170.00 million shares outstanding. The number of shares has increased by 26.67% in one year.
| Current Share Class | 170.00M |
| Shares Outstanding | 170.00M |
| Shares Change (YoY) | +26.67% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 70.59% |
| Owned by Institutions (%) | n/a |
| Float | 50.00M |
Valuation Ratios
The trailing PE ratio is 8.34.
| PE Ratio | 8.34 |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 10.41 |
| P/OCF Ratio | 5.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.25, with an EV/FCF ratio of 8.37.
| EV / Earnings | 6.70 |
| EV / Sales | 0.69 |
| EV / EBITDA | 4.25 |
| EV / EBIT | 5.29 |
| EV / FCF | 8.37 |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.31 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.37 |
| Debt / FCF | 2.71 |
| Interest Coverage | 27.29 |
Financial Efficiency
Return on equity (ROE) is 15.66% and return on invested capital (ROIC) is 22.34%.
| Return on Equity (ROE) | 15.66% |
| Return on Assets (ROA) | 7.55% |
| Return on Invested Capital (ROIC) | 22.34% |
| Return on Capital Employed (ROCE) | 17.66% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.92 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, SEI Medical PCL has paid 11.97 million in taxes.
| Income Tax | 11.97M |
| Effective Tax Rate | 20.47% |
Stock Price Statistics
The stock price has decreased by -25.49% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -25.49% |
| 50-Day Moving Average | 2.32 |
| 200-Day Moving Average | 2.58 |
| Relative Strength Index (RSI) | 45.12 |
| Average Volume (20 Days) | 277,968 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SEI Medical PCL had revenue of THB 449.68 million and earned 46.50 million in profits. Earnings per share was 0.27.
| Revenue | 449.68M |
| Gross Profit | 156.26M |
| Operating Income | 58.94M |
| Pretax Income | 58.47M |
| Net Income | 46.50M |
| EBITDA | 71.33M |
| EBIT | 58.94M |
| Earnings Per Share (EPS) | 0.27 |
Balance Sheet
The company has 176.64 million in cash and 100.81 million in debt, with a net cash position of 75.83 million or 0.45 per share.
| Cash & Cash Equivalents | 176.64M |
| Total Debt | 100.81M |
| Net Cash | 75.83M |
| Net Cash Per Share | 0.45 |
| Equity (Book Value) | 312.01M |
| Book Value Per Share | 1.84 |
| Working Capital | 238.09M |
Cash Flow
In the last 12 months, operating cash flow was 71.03 million and capital expenditures -33.78 million, giving a free cash flow of 37.25 million.
| Operating Cash Flow | 71.03M |
| Capital Expenditures | -33.78M |
| Free Cash Flow | 37.25M |
| FCF Per Share | 0.22 |
Margins
Gross margin is 34.75%, with operating and profit margins of 13.11% and 10.34%.
| Gross Margin | 34.75% |
| Operating Margin | 13.11% |
| Pretax Margin | 13.00% |
| Profit Margin | 10.34% |
| EBITDA Margin | 15.86% |
| EBIT Margin | 13.11% |
| FCF Margin | 8.28% |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 4.82%.
| Dividend Per Share | 0.11 |
| Dividend Yield | 4.82% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 43.81% |
| Buyback Yield | -26.67% |
| Shareholder Yield | -21.84% |
| Earnings Yield | 12.00% |
| FCF Yield | 9.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SEI Medical PCL has an Altman Z-Score of 3.57 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.57 |
| Piotroski F-Score | 5 |